Home › Peripheral Arterial Disease › Virginia › Norfolk
Peripheral Arterial Disease clinical trials in Norfolk, VA
5 studies for Peripheral Arterial Disease are looking for participants at sites in and around Norfolk (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Tidewater Kidney Specialists, Norfolk
The THOR IDE Study
Recruiting
- Sentara Health Research Center, Norfolk
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
Recruiting
- Sentara Medical Group, Norfolk
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
Recruiting
- Sentara Norfolk General Hospital, Norfolk
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RecruitingPhase 3
- Sentara Norfolk General Hospital, Norfolk
About Peripheral Arterial Disease
Peripheral arterial disease (PAD) happens when there is a narrowing of the blood vessels outside of your heart. Learn about symptoms and treatment.
More about Peripheral Arterial Disease on MedlinePlus
Peripheral Arterial Disease trials in other cities
- Chicago, IL9 studies
- Dallas, TX9 studies
- Cleveland, OH9 studies
- Boston, MA9 studies
- Houston, TX8 studies
- Gainesville, FL7 studies
- Omaha, NE7 studies
- Nashville, TN6 studies
- Aurora, CO6 studies
- Minneapolis, MN6 studies
- Miami, FL6 studies
- New Haven, CT5 studies
Other studies in Norfolk
- Breast Cancer16 studies
- Prostate Cancer8 studies
- Bladder Cancer8 studies
- Ovarian Cancer7 studies
- Non-Small Cell Lung Cancer7 studies
- Abdominal Aortic Aneurysm7 studies
- Heart Failure7 studies
- Cancer (all types)7 studies
- Cardiovascular Disease7 studies
- Spinal Muscular Atrophy6 studies
- Triple-Negative Breast Cancer5 studies
- Acute Lymphoblastic Leukemia5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.